Group 1 - Senyuan Electric signed a strategic cooperation agreement with Xuchang Digital Supply Chain Management Co., aiming for annual business cooperation not exceeding 500 million yuan over 36 months [1] - CICC's subsidiary, CICC Wealth, reported a net profit of 987 million yuan for the first half of the year, with total assets of 193.37 billion yuan [2] - Shuangjie Electric expects a net profit of 100 million to 120 million yuan for the first half of the year, representing a year-on-year increase of 16.03% to 39.23% [3][4] - Shentong Technology reported a net profit of 64.28 million yuan for the first half of the year, a year-on-year increase of 111.09% [5] - Suqian Nongfa's net profit for the first half of the year decreased by 27.72% to 213 million yuan [6] Group 2 - Fuan Pharmaceutical expects a net profit decline of 39.95% to 53.81% for the first half of the year, estimating between 100 million to 130 million yuan [8] - Xingwang Yuda anticipates a net loss of 11 million to 21 million yuan for the first half of the year [9] - Pulaike received a new veterinary drug registration certificate for a vaccine aimed at preventing chicken diseases [10] - Yuandong Biological's ephedrine injection received a drug registration certificate for treating low blood pressure during anesthesia [11] - Suqian Liansheng's subsidiary obtained two invention patent certificates [12] Group 3 - Oke Technology signed a 176 million yuan equipment order with Jiangxi Tianhong New Materials [13] - Publishing Media announced the resignation of its chief accountant due to work changes [15] - Zhongxin Co. plans to use 40 million yuan of idle funds for cash management [16] - Huiyun Titanium plans to use up to 58 million yuan of idle convertible bond funds for cash management [18] - Haineng Technology intends to apply for a credit facility of up to 200 million yuan from a bank [20] Group 4 - Jiabiou expects a net profit increase of 57.61% for the first half of the year, estimating around 107 million yuan [21] - Nanjing Gaoke reported a 1185% year-on-year increase in contract sales area for the second quarter [22] - Shuguang Co. received approval for a specific stock issuance application [23] - Huadong Pharmaceutical's subsidiary received approval for a clinical trial of a new drug targeting advanced solid tumors [23] - Quicheng Co. plans to invest 900 million yuan in two new projects [25] Group 5 - Shenlian Biological's vaccine for avian adenovirus received a new veterinary drug registration certificate [26] - Rike Chemical signed a strategic cooperation framework agreement with Dongming Petrochemical [28] - Jincheng Pharmaceutical's subsidiary received a renewed tobacco production license [29] - Magmi Te's stock issuance application was accepted by the Shenzhen Stock Exchange [29] - Zhongyin Securities received approval to issue bonds totaling up to 14 billion yuan [29] Group 6 - Hewei Electric's executives plan to reduce their holdings by a total of 2.24% of the company's shares [44] - Guo Wang Xintong reported a net profit of 266 million yuan for the first half of the year, a decrease of 10.82% [45] - Guo Wang Xintong's subsidiary won a 966 million yuan tender from the State Grid [46] - Jicheng Electronics won contracts worth approximately 83.79 million yuan from the State Grid [48] - Helen Piano is planning a change of control, leading to a temporary stock suspension [48]

一、发明专利证书基本情况 证券代码：603065 证券简称：宿迁联盛 公告编号：2025-044 宿迁联盛科技股份有限公司 关于全资子公司取得发明专利证书的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 宿迁联盛科技股份有限公司（以下简称"公司"）全资子公司宿迁盛瑞新材 料有限公司于近期取得 2 项国家知识产权局颁发的发明专利证书。具体情况如下： | 序 | 发明名称 | 专利号 | 专利申请 | | 授权公告 | 专利权 | 专利权期 | | --- | --- | --- | --- | --- | --- | --- | --- | | 号 | | | 日 | | 日 | 人 | 限 | | 1 | 一种利用金属铝负载的 大孔磺酸型树脂催化剂 制备 阻聚剂的合成 706 | ZL 2022 1 1472839.6 | 2022 月 11 | 年 23 | 2025 年 月 07 15 | 宿迁盛 瑞新材 料有限 | 20 年（自 申请日起 | | | 方法 | | 日 | | 日 | 公司 | 算） | | 2 | ...

Company and Industry Summary Company Overview - The company is a large enterprise established in March 2011, with a registered capital of 418.97 million yuan and covering an area of approximately 1,600 acres. It was listed on the Shanghai Stock Exchange in March 2023. The company specializes in chemical research and development, production, sales, and technical trade, and is a major producer in the global market for various chemical products [1] Key Financial Metrics - For the fiscal year 2024, the company reported total assets of 3.398 billion yuan, an increase of 5.32% year-over-year. Operating revenue reached 1.504 billion yuan, up 6.11% year-over-year, with main business revenue at 1.496 billion yuan, reflecting a 6.30% increase [2] - The company's main business costs were 1.293 billion yuan, which increased by 13%. The net profit attributable to shareholders was 39.36 million yuan, a significant decline of 47.59% year-over-year. The profit excluding non-recurring gains and losses was 22.11 million yuan, down 65.17% [2] Market Performance - Domestic sales in China amounted to 748.08 million yuan, a rise of 15.89% year-over-year, while international sales were 748.28 million yuan, showing a decline of 1.75% [3] - The chemical industry segment saw a decrease in sales by 7.82%, while the equipment industry experienced a substantial increase in revenue by 221.68% [3] Product Performance - The sales volume of the main product, the hindered amine light stabilizer, increased by 17.87%, but the selling price decreased by 8.69% due to intense market competition, leading to a decline in gross margin by 4.95 percentage points [4] - The company has optimized production processes to improve efficiency, but the increase in raw material costs (up 5.94% and 10.71% year-over-year) has affected the overall cost structure [3] Recent Developments - In the first quarter of 2025, the company reported operating revenue of 304.65 million yuan, a decrease of 3.09% year-over-year, with a net profit of 781,600 yuan, down 28.72% [4] - The company initiated a share buyback program, repurchasing 3.5267 million shares, representing 0.84% of the total share capital, with a total transaction amount of approximately 25.01 million yuan [5] Dividend Distribution - For the fiscal year 2024, the company declared a cash dividend totaling approximately 54.11 million yuan, with a distribution of 1.00 yuan per ten shares [6]

Group 1 - The major shareholders of Suqian Liansheng (603065.SH) have announced plans to reduce their holdings, with significant stakes held by Fangyuan Zhihuo, Coastal Investment, XGBS Venture Capital, and Bansheng Juyuan [1][2] - Fangyuan Zhihuo plans to reduce up to 12,569,027 shares, representing 3% of the total share capital, during the period from July 31, 2025, to October 31, 2025 [2] - Coastal Investment, XGBS Venture Capital, and Bansheng Juyuan collectively plan to reduce up to 12,690,000 shares, accounting for 3.03% of the total share capital, within the same timeframe [2] Group 2 - Suqian Liansheng was listed on the Shanghai Stock Exchange on March 21, 2023, with an issuance of 41.9 million shares at a price of 12.85 yuan per share [3] - The stock reached its highest price of 22.39 yuan on March 23, 2023, but has since experienced a decline and is currently trading below its initial offering price [3] - The total funds raised from the IPO amounted to 538.415 million yuan, with a net amount of 466.6271 million yuan allocated for the construction of products such as light stabilizers and key intermediates [3]

Group 1 - Company Junhe Precision expects a net profit of 49.3 million to 53 million yuan for the first half of 2025, representing a year-on-year increase of 46.61% to 57.61% [1] - Company Yingtan plans to reduce its shareholding by a total of 2.79%, with specific reductions from major shareholders and executives due to funding needs [1][2] - Company EFORT W.F.C. Holding plans to sell 22% of its stake in GME Aerospace for 6 million euros, reducing its ownership from 48.99% to 19.76% [2] - Company Huada Jiutian has terminated its major asset restructuring plans due to a lack of consensus on key terms among parties involved [3] - Company Shankai Intelligent is planning a change in control, leading to a temporary suspension of its stock trading [3] Group 2 - Company TCL Technology anticipates a revenue of 82.6 billion to 90.6 billion yuan for the first half of 2025, with a net profit increase of 81% to 101% [5][6] - Company TCL Zhonghuan expects a net loss of 4 billion to 4.5 billion yuan for the first half of 2025, worsening from the previous year [6] - Company Lvtianhua forecasts a net profit decline of 62.64% to 73.85%, estimating a profit of 3.5 million to 5 million yuan [8] - Company Zhongke Jincai expects a net loss of 75 million to 105 million yuan, representing a decline of 51.43% to 112% [9] - Company AVIC Heavy Machinery anticipates a net profit decrease of approximately 33.29% for the first half of 2025 [11] Group 3 - Company Jiangbolong reports that the National Integrated Circuit Industry Investment Fund has reduced its stake to below 5% [13] - Company Erlu Si plans to reduce its shareholding by up to 1% due to personal funding needs [14] - Company Zhonghua Rock intends to reduce its shareholding by up to 0.46% for personal funding reasons [15] - Company Jiekang Equipment plans to reduce its shareholding by up to 1% due to personal funding needs [15] - Company Jianzhijia's actual controller plans to increase its shareholding by 50,000 to 100,000 shares [16] Group 4 - Company Jinshi Resources has had a lawsuit terminated after the plaintiff withdrew their case, which had sought 90 million yuan in damages [18] - Company Huaye Fragrance plans to reduce its shareholding by up to 3% due to personal financial arrangements [19] - Company Zhaobiao plans to reduce its shareholding by a total of 0.54% due to personal funding needs [20] - Company Shenkai plans a full takeover offer at 16.13 yuan per share for 8659 million shares, representing 57.73% of its issued shares [21] - Company Suqian Liansheng plans to reduce its shareholding by a total of 6.03% due to personal funding needs [22]

股份实施细则》，方源智合已通过中国证券投资基金业协会的政策备案 申请，可适用上述减持规定。截至本公司首次公开发行上市日，方源 智合对本公司的投资期限在 36 个月以上但不满 48 个月，通过集中竞 价交易方式减持的，在任意连续 60 日内减持股份的总数不得超过公司 股份总数的 1%；通过大宗交易方式减持的，在任意连续 60 日内减持股 份的总数不得超过公司股份总数的 2%。 证券代码：603065 证券简称：宿迁联盛 公告编号：2025-043 宿迁联盛科技股份有限公司 关于 5%以上股东持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 1 大股东的基本情况：截至本公告披露日，宁波梅山保税港区方源智合 投资管理合伙企业（有限合伙）（以下简称"方源智合"）共持有宿迁 联盛科技股份有限公司（以下简称"公司"）30,568,557 股，其持有股 份占公司总股本的 7.30%，江苏沿海产业投资基金（有限合伙）（以下 简称"沿海投资"）共持有公司 34,280,000 股，其持有股份占公司总 股本 ...

Group 1 - The core point of the article is that Suqian Liansheng (603065.SH) announced a share reduction plan from its shareholders, which may lead to a decrease in the company's stock price [1] - Shareholder Fangyuan Zhihuo plans to reduce its holdings by up to 12.569 million shares, accounting for 3% of the company's total share capital [1] - Shareholders Yanhai Investment, Xinguang Bangsheng, and Bangsheng Juyuan plan to collectively reduce their holdings by up to 12.69 million shares, representing 3.03% of the company's total share capital [1]

Core Viewpoint - The announcement details the share pledge situation of Suqian Liansheng Technology Co., Ltd. by its controlling shareholder, Suqian Liantao Holdings (Group) Co., Ltd., indicating a total of 20 million shares pledged, which represents 25% of the shares held by the controlling shareholder and 4.77% of the company's total share capital [1][2]. Group 1: Share Pledge Details - Suqian Liantao Holdings holds 80 million shares, accounting for 19.09% of the total share capital of the company [1]. - After the pledge, the total number of shares pledged by Liantao Holdings is 20 million, which is 25% of its holdings and 4.77% of the company's total share capital [1]. - Liantao Holdings and its concerted actors collectively hold 205,594,117 shares, representing 49.06% of the total share capital, with 20 million shares pledged, which is 9.73% of their total holdings [1][2]. Group 2: Risk Assessment - The credit status of Liantao Holdings is good, and it has the ability to repay the funds, with no current risk of forced liquidation or transfer of pledged shares [2]. - The share pledge risk is considered controllable and will not lead to a change in the actual control of the company or involve significant asset restructuring obligations [2]. - The company will continue to monitor the share pledge situation and disclose relevant information in a timely manner [3].

证券代码：603065 证券简称：宿迁联盛 公告编号：2025-042 一、上市公司股份质押 公司于近日获悉控股股东联拓控股所持有公司的部分股份被质押。具体情况 如下： 1 股东名 称 是否 为控 股股 东 本次质押股 数（股） 是否为限 售股（如 是，注明 限售类 型） 是否 补充 质押 质押起 始日 质押到 期日 质权人 占其所 持股份 比例 占公 司总 股本 比例 质押 融资 资金 用途 联拓控 股 是 20,000,000 是（首发 限售股） 否 2025/7/7 2026/7/7 国泰海 通证券 股份有 限公司 25.00% 4.77% 补充 流动 资金 1.本次股份质押基本情况 | | | 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 宿迁联盛科技股份有限公司（以下简称"公司"）控股股东宿迁联拓控股 （集团）有限公司（以下简称"联拓控股"）持有公司股份 80,000,000 股，占公 司总股本比例 19.09%，本次股份质押后，联拓控股累计质押 20,000,000 股，占 其所持公司股份的 25 ...

Group 1 - Shengde Xintai won a bid for a thermal power steel pipe project worth approximately 217 million yuan, accounting for 8.15% of its audited revenue for 2024 [1] - High-speed Electric's subsidiary won a project for the Shanghai-Nanjing-Hefei high-speed railway, with a bid amount of 71.76 million yuan [1] - Cangge Mining's subsidiary received a construction permit for a lithium-boron mining project, with a construction area of 106,900 square meters [2] Group 2 - China Electric Power Construction signed a mining transportation project contract in Guinea worth approximately 5.063 billion yuan, with a total duration of about 72 months [3] - Guobang Pharmaceutical's subsidiary completed the registration of an equity investment fund focusing on strategic emerging industries [4] - Deshi Co. obtained two invention patents related to oil and gas field development [5][26] Group 3 - Xue Tian Salt Industry expects a significant decrease in net profit for the first half of 2025, projecting a decline of 76.34% to 80.29% [6] - Rundu Co. received a drug registration certificate for moxifloxacin hydrochloride tablets, used for treating various bacterial infections [7] - China Nuclear Power reported a 15.65% increase in power generation in the first half of the year, with nuclear power generation up by 12.01% [8] Group 4 - Suqian Liansheng obtained two invention patents related to wastewater treatment methods [9] - Boshi Co. signed a 109 million yuan operation and maintenance service contract for solid product packaging [11] - *ST Sailong's subsidiary received a drug registration certificate for torasemide injection, used for various medical conditions [13] Group 5 - North Bay Port reported a 10.95% increase in cargo throughput for the first half of 2025, with container throughput also showing growth [14] - Kaiwei Te expects a revenue increase of 56.17% to 90.87% for the first half of 2025 [15] - Wankai New Materials plans to reduce production and conduct maintenance on 60,000 tons of PET capacity, affecting overall performance [16] Group 6 - Haiwang Bio's HW130 injection successfully completed Phase I clinical trials, showing good safety and tolerability [19] - Zhenai Meijia received a total of 22.8 million yuan in compensation for land acquisition, which will significantly impact its 2025 performance [20] - Changyuan Electric reported a 23.58% decrease in power generation in June, with a notable decline in thermal power generation [21] Group 7 - Shouxiangu's subsidiary completed the registration of two health food products [22] - Kailun Co. announced the resignation of its deputy general manager and board secretary [23] - Xibu Muye reported a 2.15% year-on-year increase in fresh milk production in June [24] Group 8 - Deshi Co. obtained two invention patents related to oil and gas field development [26] - Jingwei Huikai plans to acquire a 12.44% stake in Nuo Si Micro for 149 million yuan [27] - Electric Alloy completed the registration of its subsidiary in Mexico [29] Group 9 - Meinuohua expects a net profit increase of 142.84% to 174.52% for the first half of 2025 [30] - Guizhou Moutai repurchased approximately 3.38 million shares, accounting for 0.2692% of its total share capital [31][32] - Warner Pharmaceutical received approval for the listing application of a raw material drug for treating respiratory diseases [34] Group 10 - Yuan Dong Bio's independent director is under investigation for serious violations [35] - Dash Intelligent signed a contract for a smart project worth 11.88 million yuan [36] - Dayou Energy plans to transfer 586,500 tons of coal production capacity replacement indicators [37] Group 11 - Foton Motor reported a 150.96% increase in new energy vehicle sales in the first half of 2025 [39] - Renfu Pharmaceutical's shareholder plans to increase its stake by 1% to 2% [40] - Zongshen Power expects a net profit increase of 70% to 100% for the first half of 2025 [42] Group 12 - Yingboer plans to sell its wholly-owned subsidiary for 239 million yuan [44] - Changan Automobile reported a 1.59% increase in total vehicle sales in the first half of 2025 [46] - Fulian Precision signed a cooperation framework agreement with Sichuan Development Longmang [48] Group 13 - Nengte Technology plans to repurchase shares worth 300 million to 500 million yuan [50] - Longsoft Technology's controlling shareholder donated 3.43% of the company's shares [51] - Data Port's shareholders plan to reduce their holdings by up to 2% [52]